nimotuzumab(828933-51-3)
- Name: nimotuzumab
- Synonyms:nimotuzumab
- Molecular Formula:
- Molecular Weight:0
- CAS Registry Number:828933-51-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.828933-51-3 nimotuzumab
Assay:99% Appearance:liquid Package:Inside plastic outside Storage:2-8掳C Transportation:We ship goods via DHL, Fedex, UPS, TNT, China post, NL Post and other couriers, weight from 1g to 1000kg or even bulker Application:Scientific research
Min. Order:1Gram
Supplier:Hebei Nengqian Chemical Import and Export Co., LTD [
China (Mainland)] CAS No.828933-51-3 nimotuzumab
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:nimotuzumab
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.828933-51-3 nimotuzumab
Assay:97% Appearance:white to beige crystals Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States] CAS No.828933-51-3 Nimotuzumab CAS No.828933-51-3
Assay:99.90% Appearance:solid or liquid Package:As customer's requested Storage:sealed in cool and dry place Transportation:by courier/air/sea Application:Pharma Intermediate
Min. Order:0
Supplier:Guangdong Juda Chemical Industrial Co.,Limited [
China (Mainland)]
Other Product
- 912773-00-3/3-NITRO-4-(1H-1,2,4-TRIAZOL-1-YL)PYRIDINE
- 639089-15-9/3-[3-(1H-IMIDAZOL-4-YL)-PROPYL]-PIPERIDINE 2HBR
- 1381944-57-5/2-(3-Fluorophenyl)-2-Methylpropan-1-aMine hydrochloride
- 912966-14-4/Pyrido[2,3-d]pyrimidine-6-carbonitrile, 8-(4-ethoxyphenyl)-1,4,7,8-tetrahydro-2-methyl-4,7-dioxo-5-phenyl- (9CI)
- 87535-27-1/Butanamide, N-hydroxy-N-methyl-3-oxo- (9CI)
- 575497-40-4/(1,4,5,6-TETRAHYDRO-PYRIMIDIN-2-YLSULFANYL)-ACETIC ACID
- 87019-31-6/BETA-D-GAL-[1->4]-BETA-D-GLCNAC-1->O-CETE
- 1124147-33-6/4-bromo-2-tert-butyl-6-(trifluoromethyl)pyrimidine
- 37167-63-8/(R)-ETHYL 1-BROMO-1-PHENYL ACETATE
- 676448-42-3/1,2,3-Cyclopentanetriol,4-hydrazino-,1-acetate,(1S,2S,3S,4R)-(9CI)
- 1296114-57-2/diMethyl 5,5-difluorocyclohexane-1,3-dicarboxylate
- 902093-29-2/N-(4-BroMo-2-chlorophenyl)-2-fluorobenzaMide, 97%
- 334704-98-2/5(4H)-Oxazolone,4-cyclopentyl-2-methyl-(9CI)
- 1155847-28-1/methyl 2-(1H-pyrazolo[3,4-b]pyridin-3-yl)acetate
- 1353973-91-7/[1-(6-Methoxy-pyriMidin-4-yl)-piperidin-3-ylMethyl]-carbaMic acid tert-butyl ester
- 1038393-47-3/Benzenemethanamine, .alpha.-methyl-4-(methylsulfonyl)-, (.alpha.R)-
- 1019455-02-7/2-(2-nitrobenzylthio)-5-chlorobenzenamine
- 35146-60-2/N2,N5-Bis(1-oxodecyl)-L-Orn-L-Ala-L-Ala-L-Phe-OMe
- 70000-59-8/AKOS B023209
- 828933-51-3/nimotuzumab
- 691886-10-9/4-chloro-6-methyl-5-propylpyrimidine
- 1214330-74-1/3-Methoxy-6-(trifluoroMethyl)picolinic acid
- 898757-65-8/ETHYL 7-OXO-7-(4-N-PROPOXYPHENYL)HEPTANOATE
- 62185-39-1/2,3-dimethyl-3-isopropylheptane
- 97828-37-0/Piritramide dihydrochloride
- 90226-22-5/Methyl-((1Ξ,3R)-3-Methyl-cyclohexyl)-aMine
- 134931-01-4/(9Z)-ErythroMycin A OxiMe
- 1352394-23-0/3-DibroMo-6-ethyl-2-oxy-5-azaindole
- 125511-54-8/Proline 2-Methylpropyl ester
- 2881-53-0/5-Methyl-2-Morpholinobenzo[d]oxazole